CD33 and non-small cell lung carcinoma: In the NSCLC cohort, the phenotypes CD3+CD8+CD45RO+, CK+B7-H3+, CK+B7-H4+, CD3+B7-H4+, CD68+B7-H3+, CD68+B7-H4+, CK+OX40+, CD3+LAG3+, CD68+Arg-1+, CD66b+CD11b+, CD11b+Arg1+CD14+CD33+and CD11b+CD66b+CD33+ were observed in small quantities, and in some samples they were not found; this scarcity hindered the analysis and interpretation of those cell phenotypes, which is why those phenotypes were not included in the reproducibility analysis.